Here, we used the MPO inhibitor 4-Aminobenzoic acid hydrazide (ABAH) that has been previously shown in other studies to be beneficial against different disease models in vivo, such as experimental autoimmune encephalomyelitis and ischemic stroke [18,19,20]. The gene discussed is MPO; the disease is ischemic stroke.